Funding will support the United Nations Foundation’s Shot@Life, a grassroots advocacy campaign that champions global immunization CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–The AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization focused on supporting health-related causes that enrich the global community, has committed $150,000 to the United Nations Foundation’s Shot@Life campaign to support vaccine equity, protecting the world’s most … [Read more…]

–          Sizable and sustained improvement in Hammersmith Functional Motor Scale-Expanded (HFMSE) scores observed at 24 months –          Substantial increase in Revised Upper Limb Module (RULM) scores observed at 24 months –          No serious safety risks identified over 24 months –          Enrollment progressing in pivotal Phase 3 SAPPHIRE registrational trial –          Scholar Rock to host webcast today … [Read more…]

– Submission seeks approval of momelotinib for the treatment of myelofibrosis – SAN MATEO, Calif.–(BUSINESS WIRE)–Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company on a mission to deliver transformative therapies for rare cancers, today announced the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for momelotinib, … [Read more…]

MILWAUKEE–(BUSINESS WIRE)–Physicians Realty Trust (NYSE:DOC) (the “Company”) announced today that the Company’s Board of Trustees has authorized, and the Company has declared, a quarterly cash dividend of $0.23 per common share and unit for the quarter ending June 30, 2022. “We are proud to declare and pay our 36th consecutive quarterly dividend. Cash flows from … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “High-flow Nasal Cannula Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The High-flow Nasal Cannula market is projected to grow with a CAGR of nearly 12.4% over the forecast period. Companies Mentioned ResMed Fisher & Paykel Healthcare Limited Devatec Teleflex Incorporated Smiths Medical … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Syndromic Multiplex Diagnostic Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The syndromic multiplex diagnostic market is anticipated to grow with a CAGR of nearly 7.2% during the forecast period. Companies Mentioned BIOMERIEUX SA Qiagen Luminex Corporation Applied BioCode Akonni Biosystems Mesa Biotech … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Bacterial Conjunctivitis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the Bacterial Conjunctivitis, historical and forecasted epidemiology as well as the Bacterial Conjunctivitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Medical Imaging Market Research Report by Modality (Computed Tomography, Fluoroscopy, and Mammography), End-user, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Medical Imaging Market size was estimated at USD 16.84 billion in … [Read more…]

HONG KONG & INGELHEIM, Germany–(BUSINESS WIRE)–Hong Kong Science and Technology Parks Corporation (HKSTP) is partnering global research-driven biopharmaceutical leader, Boehringer Ingelheim Venture Fund Limited (BIVF) in a strategic co-incubation collaboration to promote and nurture startups on research and development for infectious diseases and immunology. HKSTP is dedicated to collaborating with sector leaders in building the … [Read more…]

IFPMA, the body representing biopharmaceutical companies in Geneva, expresses deep disappointment with the decision taken to adopt a TRIPS waiver, despite intellectual property (IP) not being a barrier to vaccine scale-up and wide acknowledgment of vaccines surplus. IP has enabled the rapid research and development of several effective vaccines against COVID-19 and underpinned the more … [Read more…]